Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It … Read more
Ekso Bionics Holdings Inc (EKSO) - Total Liabilities
Latest total liabilities as of December 2025: $11.08 Million USD
Based on the latest financial reports, Ekso Bionics Holdings Inc (EKSO) has total liabilities worth $11.08 Million USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ekso Bionics Holdings Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how Ekso Bionics Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ekso Bionics Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Ekso Bionics Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PVP Ventures Limited
NSE:PVP
|
India | ₹3.20 Billion |
|
EcoFirst Consolidated Bhd
KLSE:3557
|
Malaysia | RM463.23 Million |
|
NicOx S.A.
PA:ALCOX
|
France | €19.39 Million |
|
JMC Electronics Co Ltd
TW:6552
|
Taiwan | NT$1.25 Billion |
|
Broncus Holding Corporation
PINK:BRNHF
|
USA | $5.29 Million |
|
Sono-Tek Corp
NASDAQ:SOTK
|
USA | $4.80 Million |
|
Mahkota Group Tbk PT
JK:MGRO
|
Indonesia | Rp2.60 Trillion |
Liability Composition Analysis (2011–2025)
This chart breaks down Ekso Bionics Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ekso Bionics Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ekso Bionics Holdings Inc (2011–2025)
The table below shows the annual total liabilities of Ekso Bionics Holdings Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $11.08 Million | -20.52% |
| 2024-12-31 | $13.95 Million | -14.51% |
| 2023-12-31 | $16.31 Million | +5.50% |
| 2022-12-31 | $15.46 Million | +29.41% |
| 2021-12-31 | $11.95 Million | -26.08% |
| 2020-12-31 | $16.16 Million | +6.91% |
| 2019-12-31 | $15.12 Million | +1.28% |
| 2018-12-31 | $14.93 Million | -10.06% |
| 2017-12-31 | $16.60 Million | -7.25% |
| 2016-12-31 | $17.89 Million | -23.50% |
| 2015-12-31 | $23.39 Million | +119.13% |
| 2014-12-31 | $10.67 Million | +75473.49% |
| 2013-12-31 | $14.12K | 0.00% |
| 2012-12-31 | $14.12K | +74.37% |
| 2011-12-31 | $8.10K | -- |